title: Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy.
abstract: The aim of this prospective study was to evaluate the efficacy and safety of enhanced detection criteria, stability and sudden onset, for ventricular tachycardia (VT) in the therapy of implantable cardioverter-defibrillators (ICDs). These detection enhancements ensure a high specificity in detecting VT, thereby avoiding inappropriate therapy delivery due to supraventricular tachycardia. However, delayed sensing or even undersensing of VT may lead to a problematic, even fatal, outcome. In our study, the stability detection enhancement was programmed to discriminate atrial fibrillation (AF) in 84 of 124 patients with implanted ICDs and the sudden-onset detection enhancement in 47 of the 124 patients to discriminate sinus tachycardia. Using these enhancements in 124 patients with third-generation ICDs, 13 patients (11%) had inappropriate therapy during 20 months of follow-up. AF caused shock delivery in 6 patients (5%) and antitachycardia pacing in 4 patients, atrial flutter triggered shock therapy in 1 patient, and sinus tachycardia caused shock delivery in 2 patients. In 3 of the 13 patients inappropriate therapy recurred despite reprogramming the detection enhancements. The stability parameter of 241 spontaneous VT episodes as measured by the devices was 8 +/- 7 msec. Only 10 (4%) VTs had a stability parameter >25 msec. In 46 patients a combination of both detection enhancements, stability and/or sudden onset, were programmed. The use of detection enhancements proved safe and no patient had suffered negative side effects due to prolonged detection time or therapy delay. Inappropriate shock delivery due to AF, a major complication in ICD therapy, was reduced to 5% of patients. The use of the stability enhancement is recommended for patients with intermittent or chronic AF. Selected patients profit from programming both the stability and sudden onset criteria.
authors.affiliation: University of Göttingen, Department of Cardiology, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Schaumann
authors.forename: F
authors.initials: F
authors.lastname: von zur Mühlen
authors.forename: B D
authors.initials: BD
authors.lastname: Gonska
authors.forename: H
authors.initials: H
authors.lastname: Kreuzer
mesh_terms: D000293:Adolescent; D000328:Adult; D001281:Atrial Fibrillation / Q000175:diagnosis; D002648:Child; D017147:Defibrillators, Implantable / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013616:Tachycardia, Sinus / Q000175:diagnosis; D017180:Tachycardia, Ventricular / Q000175:diagnosis* / Q000628:therapy*